Investors next week will be focusing on Wednesday consumer price index reading for February. Producer price inflation ...
BoC Interest Rate Decision (Mar.) The Bank of Canada reduced its target for the overnight rate in February to 3%, with the ...
BioNTech Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Canaccord Genuity analyst William Maughan maintained a Buy rating and increased the price target from $171 to $171.44 on Nov. 27, 2024. This analyst has an accuracy rate of 71%. JP Morgan analyst ...
SVB Wealth LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the fourth quarter, Holdings ...
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seventeen analysts that are covering the firm, Marketbeat Ratings reports. Three ...
The earnings docket features key quarterly reports from American Eagle (AEO), BioNTech (BNTX), Dick's Sporting Goods (DKS), ...
German biotech major BioNTech (Nasdaq: BNTX) has suffered a blow as it seeks to add new revenue streams beyond its COVID-19 ...
The US Patent Trial and Appeal Board handed a massive victory to Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) on Wednesday, ...
Shares in Chinese e-commerce giant Alibaba closed 8.4% higher in Asian trading hours on Thursday, as investors cheered news ...
In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...
BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results